| Anti-EBNA-1 IgG | Anti-VCA IgG | ||||
---|---|---|---|---|---|---|
CSF levels (AU) | Serum levels (AU) | AI >1.5 | CSF levels (AU) | Serum levels (AU) | AI >1.5 | |
Median; IQR | Median; IQR | n/total (%) | Median; IQR | Median; IQR | n/total (%) | |
Total RRMS (n = 100) | 79.4; 37.5 to 174.3a | 52,056; 23,274 to 94,815c, d | 6/100 (6%) | 36.4; 0.0 to 74.2 | 18962; 10659 to 46669 | 2/100 (2%) |
CA RRMS (n = 77) | 74.8; 38.2 to 167.7 | 41,783; 21,479 to 83,254 | 4/77 (5.2%) | 41.9; 0.0 to 83.1 | 22546; 12433 to 51763 | 0/77 (0%) |
CS RRMS (n = 23) | 100.4; 51.0 to 272.7 | 59833; 36072 to 261044 | 2/23 (8.7%) | 21.1; 0.0 to 59.9 | 14240; 6632 to 32515 | 2/23 (8.7%) |
Gd + RRMS (n = 37) | 90.4; 36.7 to 238.7 | 39325; 21479 to 105629 | 3/37 (8.1%) | 23.7; 0.0 to 60.9 | 16836; 12476 to 37484 | 0/37 (0%) |
Gd- RRMS (n = 63) | 79.4; 43.3 to 139.0 | 53092; 27500 to 84551 | 3/63 (4.8%) | 38.9; 0.0 to 85.1 | 21335; 10036 to 47672 | 2/63 (3.4%) |
OIND (n = 100) | 73.1; 31.0 to 151.6b | 23503; 10386 to 44089 | 6/100 (6%) | 82.7; 30.3 to 294.1e, f | 29938; 8846 to 65475 | 5/100 (5%) |
NIND (n = 100) | 49.7; 15.9 to 118.9 | 24383; 7252 to 54754 | 2/100 (2%) | 39.1; 0.0 to 130.8 | 28056; 12281 to 53124 | 1/100 (1%) |